标普和纳斯达克内在价值 联系我们

Alvotech ALVOW NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • IS • USD

SharesGrow Score
57/100
2/6 Pass
SharesGrow Intrinsic Value
$76.24
+29223.1%

Alvotech (ALVOW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

分析师预估 每股收益(EPS)为 $-0.13 和 营收为 $0.45B (下一财年).

每股收益(EPS)历史表现: 2024: 实际 $-0.87 vs 预期 $-0.13 (不及预期 -593.3%). 2025: 实际 $0.10 vs 预期 $-0.08 (超预期 +223.1%). 分析师准确度: 0%.

EPS 预测 — ALVOW

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.87 vs Est –$0.13 ▼ 85.6% off
2025 Actual $0.10 vs Est –$0.08 ▲ 181.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.

营收预测 — ALVOW

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.490B vs Est $0.454B ▲ 7.2% off
2025 Actual $0.586B vs Est $0.581B ▲ 0.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言